Locus 16: SRD5A2 (2p23.1)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs559555 |
X-11444 / X-12844 |
A/T |
7300 |
0.56 |
0.036 (0.003) |
1.24·10-44 |
show |
| rs559555 |
X-11444 |
A/T |
7313 |
0.56 |
0.033 (0.003) |
4.4·10-22 |
show |
| rs559555 |
X-11470 |
A/T |
6857 |
0.56 |
0.031 (0.004) |
6.54·10-19 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs559555 |
| Chromosomal location | Chr2: 31,664,478 (2p23.1) |
| Gene (distance) | SRD5A2 (4,935) |
| Predicted causal gene | SRD5A2 |
| Gene/protein classification | drug target |
| Metabolite (Pathway) | X-11444 (Unknown) X-12844 (Unknown) |
| Biochemical locus-metabolite relationship | SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL1856 |
| Drug information |
Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)
(more details...) |
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

